CAPLOSTATIN

Serial Number 78500335
606

Registration Progress

Application Filed
Oct 15, 2004
Under Examination
Feb 6, 2007
Approved for Publication
Oct 25, 2006
Published for Opposition
Nov 14, 2006
Registered

Trademark Image

CAPLOSTATIN

Basic Information

Serial Number
78500335
Filing Date
October 15, 2004
Published for Opposition
November 14, 2006
Abandonment Date
March 8, 2010
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 8, 2010
Classes
005

Rights Holder

Children's Medical Center Corporation

99
Address
55 Shattuck Street
Boston, MA 02115

Ownership History

Children's Medical Center Corporation

Original Applicant
99
Boston, MA

Children's Medical Center Corporation

Owner at Publication
99
Boston, MA

Legal Representation

Attorney
Michelle A. Massicotte

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

39 events
Date Code Type Description Documents
Mar 8, 2010 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 8, 2010 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
May 29, 2009 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 29, 2009 EX5G S SOU EXTENSION 5 GRANTED Loading...
May 8, 2009 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 8, 2009 EXT5 S SOU EXTENSION 5 FILED Loading...
Jan 14, 2009 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 14, 2009 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 14, 2009 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 2, 2008 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 17, 2008 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 17, 2008 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 31, 2007 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 19, 2007 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 19, 2007 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 11, 2007 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 16, 2007 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 18, 2007 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 18, 2007 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 6, 2007 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 14, 2006 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 25, 2006 NPUB O NOTICE OF PUBLICATION Loading...
Sep 27, 2006 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Sep 22, 2006 ALIE A ASSIGNED TO LIE Loading...
Sep 13, 2006 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 17, 2006 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 6, 2006 ACEC I AMENDMENT FROM APPLICANT ENTERED Loading...
Feb 21, 2006 PGRR O PETITION GRANTED - RESPONSE RECEIVED Loading...
Feb 21, 2006 FAXX I FAX RECEIVED Loading...
Feb 21, 2006 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 30, 2005 FAXX I FAX RECEIVED Loading...
Dec 30, 2005 FAXX I FAX RECEIVED Loading...
Dec 30, 2005 PETR I PETITION TO REVIVE-RECEIVED Loading...
Dec 16, 2005 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Dec 16, 2005 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
May 19, 2005 DOCK D ASSIGNED TO EXAMINER Loading...
May 19, 2005 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 19, 2005 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 22, 2004 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, angiogenesis inhibitor protein compositions for the treatment of disease and biological processes that are mediated by angiogenesis, namely, cancer, macular degeneration, diabetic retinopathy, Crohn's disease, psoriasis and arthritis
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005